| 纯度 | >95%SDS-PAGE. |
| 种属 | Human |
| 靶点 | QTRTD1 |
| Uniprot No | Q9H974 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-415aa |
| 氨基酸序列 | MGSSHHHHHHSSGLVPRGSHMGSMKLSLTKVVNGCRLGKIKNLGKTGDHT MDIPGCLLYTKTGSAPHLTHHTLHNIHGVPAMAQLTLSSLAEHHEVLTEY KEGVGKFIGMPESLLYCSLHDPVSPCPAGYVTNKSVSVWSVAGRVEMTVS KFMAIQKALQPDWFQCLSDGEVSCKEATSIKRVRKSVDRSLLFLDNCLRL QEESEVLQKSVIIGVIEGGDVMEERLRSARETAKRPVGGFLLDGFQGNPT TLEARLRLLSSVTAELPEDKPRLISGVSRPDEVLECIERGVDLFESFFPY QVTERGCALTFSFDYQPNPEETLLQQNGTQEEIKCMDQIKKIETTGCNQE ITSFEINLKEKKYQEDFNPLVRGCSCYCCKNHTRAYIHHLLVTNELLAGV LLMMHNFEHYFGFFHYIREALKSDKLAQLKELIHRQAS |
| 预测分子量 | 49 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
关于QTRTD1重组蛋白的公开研究文献较为有限，以下为基于现有领域知识的假设性示例(仅供参考，实际文献需进一步核实)：
---
1. **《QTRTD1重组蛋白的表达与功能研究》**
*作者：Zhang L, et al. (2022)*
摘要：本研究成功在大肠杆菌中表达并纯化了QTRTD1重组蛋白，验证其具有调控细胞周期进程的功能，并可能通过泛素化通路参与肿瘤发生。
2. **《Structural Characterization of QTRTD1 Recombinant Protein》**
*作者：Smith J, et al. (2021)*
摘要：通过X射线晶体学解析了QTRTD1重组蛋白的三维结构，揭示了其催化活性位点的关键氨基酸残基，为靶向药物设计提供依据。
3. **《QTRTD1重组蛋白在神经退行性疾病中的作用》**
*作者：Wang Y, et al. (2023)*
摘要：实验表明QTRTD1重组蛋白能够减少α-突触核蛋白聚集，在帕金森病模型中表现出神经保护作用，提示其潜在治疗价值。
---
**注意**：QTRTD1可能为基因命名笔误，例如已知基因**QTRT1**(Queuine tRNA-ribosyltransferase)与RNA修饰相关。建议核实基因名称或检索最新数据库(如NCBI Gene、UniProt)获取准确信息。
The QTRTD1 recombinant protein is a engineered form of the QTRT-domain containing 1 (QTRTD1) protein, produced through recombinant DNA technology to enable large-scale study and application. QTRTD1 is a relatively less characterized protein in humans, though initial studies suggest it may interact with RNA or participate in RNA metabolism, given its conserved QTRT domain—a motif linked to tRNA modification enzymes in prokaryotes and eukaryotes. Its exact biological function remains under investigation, but emerging evidence hints at potential roles in cellular processes like epigenetic regulation, stress response, or nucleic acid quality control.
Recombinant QTRTD1 is typically expressed in bacterial (e.g., *E. coli*) or mammalian cell systems, purified via affinity tags, and validated for structural integrity and activity. This engineered protein serves as a critical tool for functional studies, including *in vitro* enzymatic assays, protein-protein/DNA/RNA interaction analyses, and antibody production. Researchers also explore its involvement in diseases; for instance, dysregulation of RNA-modifying proteins is often implicated in cancers or neurological disorders, positioning QTRTD1 as a potential biomarker or therapeutic target.
Despite limited clinical data, the development of QTRTD1 recombinant protein accelerates mechanistic studies, bridging gaps in understanding its physiological relevance. Ongoing work focuses on elucidating its substrate specificity, post-translational modifications, and tissue-specific expression patterns. As RNA biology gains prominence in biomedicine, QTRTD1 exemplifies how recombinant proteins can unlock insights into poorly understood genes, paving the way for diagnostic or therapeutic innovations.
×
